Cumberland Pharmaceuticals Inc cash flow statement
In fiscal 2025, Cumberland Pharmaceuticals Inc's operations generated $4.9m of cash; it spent $97,903 on capital projects, leaving free cash flow of $4.8m. It returned $263,478 through buybacks.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | 0 | 9 | 7 | 1 | 7 | 6 | 1 | −1 | 3 | 3 | 5 | 6 | 8 | 6 | −1 | 5 | 1 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Stock-based pay | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Capital spending | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −0 | −0 | 8 | 7 | 1 | 7 | 6 | 0 | −1 | 3 | 3 | 5 | 6 | 8 | 6 | −1 | 5 | 1 |
| Free cash flow after stock pay | — | −1 | 8 | 6 | −0 | 6 | 5 | −0 | −2 | 1 | 1 | 4 | 5 | 8 | 5 | −1 | 4 | 0 |
| Share buybacks | 27 | 5 | 4 | 8 | 5 | 4 | 5 | 3 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Shares issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 476 | 1,905 | 3,899 | 844 | 187 | 3 | 387 | 169 |
| Depreciation and amortisation | 1,116 | 1,496 | 1,032 | −954 | 3,026 | 1,042 | 1,276 | −1,205 |
| Stock-based pay | 76 | 75 | 74 | 81 | 81 | 172 | 107 | 78 |
| Capital spending | 15 | 2 | 48 | 26 | 24 | −0 | 0 | 38 |
| Free cash flow | 460 | 1,902 | 3,851 | 817 | 163 | 3 | 387 | 130 |
| Free cash flow after stock pay | 384 | 1,828 | 3,777 | 737 | 82 | −169 | 280 | 53 |
| Shares issued | — | — | 4,716 | 0 | — | — | — | — |
Compare with peers
- IM Cannabis Corp. cash flow
- BGM Group Ltd. cash flow
- Sunshine Biopharma Inc. cash flow
- Biofrontera Inc. cash flow
- Scilex Holding Co cash flow
Head to head: CPIX vs IMCCBGM vs CPIXCPIX vs SBFMBFRI vs CPIX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies